Dr. Bishal Gyawali received his MBBS degree from the Institute of Medicine, Tribhuwan University, Nepal in 2011 with seven gold medals for his academic excellence. He has been honored with “Student of the Decade award” and “Best Student Award” for his academic excellence in Nepal.
Dr. Gyawali is currently undergoing his postgraduate training in medical oncology at the Graduate School of Medicine, Nagoya University, Japan, where he is also a PhD candidate under the Japanese government scholarship. He also serves as visiting faculty at the department of Hemato-Oncology in Nobel Hospital, Kathmandu, Nepal.
His areas of interest include evidence-based oncology practice, cost-effectiveness of cancer therapies and economic feasibility of cancer management in low-income countries, including metronomic therapy. He has published more than 20 peer-reviewed oncology articles, editorials, commentaries and letters in medical journals including NEJM, Lancet Oncology and Journal of Clinical Oncology. He also serves as reviewers for journals such as Annals of Internal Medicine, Journal of Global Oncology, Cancer Science, etc.
He is a member of the American Society of Clinical Oncology, European Society of Medical Oncology, Japanese Society of Medical Oncology and International Association for the Study of Lung Cancer.
He blogs “Last Month in Oncology with Dr. Bishal Gyawali” at ecancer and tweets @oncology_bg
He has launched the MGHI facebook page and will be in charge of it.